Stem cell therapeutics for cancer / (Record no. 64433)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 06983cam a2200961Ii 4500 |
001 - CONTROL NUMBER | |
control field | sulb-eb0032781 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | BD-SySUS |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20170713221343.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 130810t20132013njua ob 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | EBLCP |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | EBLCP |
Modifying agency | DG1 |
-- | IDEBK |
-- | CUS |
-- | N$T |
-- | COO |
-- | OCLCQ |
-- | NLGGC |
-- | DEBBG |
-- | MMU |
-- | OCLCF |
-- | BD-SySUS |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9781118282427 (hardback : alk. paper) |
Canceled/invalid ISBN | 1118282426 (hardback : alk. paper) |
International Standard Book Number | 9781118660331 |
Qualifying information | (electronic bk. : PDF) |
International Standard Book Number | 1118660331 |
Qualifying information | (electronic bk. : PDF) |
International Standard Book Number | 9781118660423 |
Qualifying information | (electronic bk.) |
International Standard Book Number | 1118660420 |
Qualifying information | (electronic bk.) |
International Standard Book Number | 9781118660492 |
Qualifying information | (electronic bk. : Mobi) |
International Standard Book Number | 1118660498 |
Qualifying information | (electronic bk. : Mobi) |
International Standard Book Number | 9781118660621 |
Qualifying information | (electronic bk. : ePub) |
International Standard Book Number | 1118660625 |
Qualifying information | (electronic bk. : ePub) |
International Standard Book Number | 9781299776555 |
Qualifying information | (electronic bk. : MyiLibrary) |
International Standard Book Number | 1299776558 |
Qualifying information | (electronic bk. : MyiLibrary) |
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
OCLC library identifier | AU@ |
System control number | 000052006077 |
OCLC library identifier | CHBIS |
System control number | 010027043 |
OCLC library identifier | CHVBK |
System control number | 306232995 |
OCLC library identifier | DEBBG |
System control number | BV041572459 |
OCLC library identifier | NZ1 |
System control number | 15341779 |
OCLC library identifier | DEBBG |
System control number | BV041908999 |
OCLC library identifier | DEBBG |
System control number | BV043396140 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)855504053 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC271.C44 |
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | QZ 266 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | HEA |
Subject category code subdivision | 039000 |
Source | bisacsh |
Subject category code | MED |
Subject category code subdivision | 014000 |
Source | bisacsh |
Subject category code | MED |
Subject category code subdivision | 022000 |
Source | bisacsh |
Subject category code | MED |
Subject category code subdivision | 112000 |
Source | bisacsh |
Subject category code | MED |
Subject category code subdivision | 045000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.99 |
-- | 616.99406 |
049 ## - LOCAL HOLDINGS (OCLC) | |
Holding library | MAIN |
245 00 - TITLE STATEMENT | |
Title | Stem cell therapeutics for cancer / |
Statement of responsibility, etc. | editor, Khalid Shah. |
250 ## - EDITION STATEMENT | |
Edition statement | First edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Hoboken, N.J. : |
Name of producer, publisher, distributor, manufacturer | Wiley Blackwell, |
Date of production, publication, distribution, manufacture, or copyright notice | [2013] |
Date of production, publication, distribution, manufacture, or copyright notice | ©2013 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (xi, 292, 47, [1] pages) : |
Other physical details | illustrations (chiefly color) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
Content type term | still image |
Content type code | sti |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
500 ## - GENERAL NOTE | |
General note | Edition statement from running title area. |
588 0# - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Description based on online resource; title from resource home page (ebrary, viewed March 8, 2016). |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Section 1: Introduction. Stem cell sources and their potential for cancer therapeutics / Khalid Shah -- Section 2: Migration and fate of stem cells. The role of CXCR4 as a mediator of glioma-tropic neural precursor cell migration / Moneeb Ehtesham, Elliot Min, and Rebecca Kasl -- Tumor tropism of mesenchymal stem cells / Paula Y. P. Lam and Ivy A.W. Ho -- Section 3: Stem cell therapy in brain cancer. Stem cell-mediated TRAIL therapy for highly aggressive brain tumors / Khalid Shah -- Stem cell-mediated prodrug gene therapy of high-grade brain tumors / Cestmir Altaner -- Role of naïve cord blood stem cells in glioma therapy / Venkata Ramesh Dasari, Kiran Kumar Velpula, and Jasti S. Rao -- Stem cell-based antiangiogenic therapies for brain tumors / Navid Redjal and Khalid Shah -- Treatment of metastatic neuroblastoma with mesenchymal stem cell-based oncolytic virotherapy / Manuel Ramírez and Javier García-Castro -- Section 4: Stem cell therapy in other cancer types. Umbilical cord matrix stem cells for cytotherapy of breast cancer / Naomi Ohta, Atsushi Kawabata, Deepthi Uppalapati, Susumu Ishiguro, Deryl Troyer, and Masaaki Tamura -- Mesenchymal stromal cells as effective tumor antigen-presenting cells in cancer therapeutics / Raphaëlle Romieu-Mourez and Jacques Galipeau -- Diagnostic and therapeutic mesenchymal stem cells for breast cancer treatment / Róisín Dwyer -- Genetically engineered stem cell therapies targeting gastrointestinal malignancy / Emily Keung, Peter J. Nelson, and Claudius Conrad -- Mesenchymal stem cells in prostate cancer: clinical opportunities / Diptiman Chanda and Selvarangan Ponnazhagan -- Primed mesenchymal stromal cells for cancer therapy / Augusto Pessina, Arianna Bonomi, Eugenio Parati, Roberto Pallini, and Giulio Alessandri -- Section 5: Combinatorial stem cell therapies. MicroRNA adjuvants in stem cell-based cancer therapy / Maarten C. J. Anderegg and Maarten F. Corsten -- Stem cell-based combination therapies for cancer: systemic delivery of a PI K/mTOR inhibitor (PI-103) and stem cell-mediated delivery of TRAIL in brain tumors / Tugba Bagci-Onder -- The efficacy of clinically approved agents with stem cell-delivered therapeutics for cancer therapy / Hiroaki Wakimoto and Khalid Shah -- Section 6: Tracking stem cells and stem cell-based therapeutics. Imaging migration and fate of stem cells in experimental models of cancer / Deepak Bhere and Khalid Shah -- Multifunctional molecules for interrogating stem cell-based therapeutics / Shawn Hingtgen -- Tracking cancer-targeted MSC with PET imaging / Véronique Roelants and Jean-Louis Vanoverschelde. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | "Stem Cell Therapeutics for Cancer covers the application of stem cells in various cancers, with an emphasis on the aspects of these strategies that are critical to the success of future stem cell-based therapies for cancer. Topics covered in the book include stem cell sources, tumor specificity, targeted therapeutics, visualizing the stem cell, and therapeutic agent pharmacokinetics. Each chapter contains a brief introduction to the cancer, followed by an exploration of how engineered stem cells have been utilized to cure the disease in mouse models and in early phase clinical trials"--Publisher's description. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Tumors. |
Topical term or geographic name as entry element | Mesenchymal stem cells. |
Topical term or geographic name as entry element | Stem cells. |
Topical term or geographic name as entry element | Neoplasms |
General subdivision | therapy. |
Topical term or geographic name as entry element | Stem Cells |
General subdivision | physiology. |
Topical term or geographic name as entry element | Mesenchymal Stromal Cells |
General subdivision | physiology. |
Topical term or geographic name as entry element | Mesenchymal Stem Cell Transplantation |
General subdivision | methods. |
Topical term or geographic name as entry element | Mesenchymal stem cell transplantation |
General subdivision | Methods. |
Topical term or geographic name as entry element | Mesenchymal stromal cells |
General subdivision | Physiology. |
Topical term or geographic name as entry element | Neoplasms |
General subdivision | Therapy. |
Topical term or geographic name as entry element | Stem cells |
General subdivision | Physiology. |
Topical term or geographic name as entry element | HEALTH & FITNESS |
General subdivision | Diseases |
-- | General. |
Source of heading or term | bisacsh |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Clinical Medicine. |
Source of heading or term | bisacsh |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Diseases. |
Source of heading or term | bisacsh |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Evidence-Based Medicine. |
Source of heading or term | bisacsh |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Internal Medicine. |
Source of heading or term | bisacsh |
Topical term or geographic name as entry element | Mesenchymal stem cells. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst01763304 |
Topical term or geographic name as entry element | Stem cells. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst01132975 |
Topical term or geographic name as entry element | Tumors. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst01158759 |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shah, Khalid, |
Relator term | editor. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Title | Stem cell therapeutics for cancer. |
Place, publisher, and date of publication | Hoboken, N.J. : John Wiley & Sons, ©2013 |
International Standard Book Number | 9781118282427 |
Record control number | (DLC) 2013010437 |
-- | (OCoLC)830669076 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://onlinelibrary.wiley.com/book/10.1002/9781118660423">http://onlinelibrary.wiley.com/book/10.1002/9781118660423</a> |
Public note | Wiley Online Library [Free Download only for SUST IP] |
938 ## - | |
-- | EBL - Ebook Library |
-- | EBLB |
-- | EBL1332525 |
-- | EBSCOhost |
-- | EBSC |
-- | 622796 |
-- | Ingram Digital eBook Collection |
-- | IDEB |
-- | cis26003244 |
994 ## - | |
-- | 92 |
-- | DG1 |
No items available.